Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
BP is eying two major projects that could help decarbonize Northwest Indiana's heavy industry, including its BP Whiting Refinery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results